NASDAQ:AXSM
$70.27
(
-1.72%
)
Friday, 27th Jan 2023
Axsome Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $59.82 | $78.90 | Friday, 27th Jan 2023 AXSM stock ended at $70.27. This is 1.72% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 5.42% from a day low at $69.18 to a day high of $72.93. |
| 90 days | $42.27 | $82.00 | |
| 52 weeks | $20.63 | $82.00 |
Historical Axsome Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $71.29 | $72.93 | $69.18 | $70.27 | 722 578 |
| 2023-01-26 | $74.36 | $75.59 | $70.88 | $71.50 | 556 590 |
| 2023-01-25 | $70.89 | $74.10 | $70.59 | $73.98 | 788 794 |
| 2023-01-24 | $69.00 | $70.81 | $68.33 | $70.81 | 698 139 |
| 2023-01-23 | $71.03 | $73.40 | $69.50 | $69.75 | 976 858 |
| 2023-01-20 | $69.46 | $71.24 | $68.28 | $70.83 | 970 335 |
| 2023-01-19 | $69.78 | $73.04 | $67.24 | $68.05 | 988 105 |
| 2023-01-18 | $68.14 | $70.21 | $67.68 | $70.03 | 762 877 |
| 2023-01-17 | $66.96 | $69.63 | $65.54 | $68.19 | 686 003 |
| 2023-01-13 | $64.10 | $67.67 | $64.10 | $67.30 | 1 114 237 |
| 2023-01-12 | $62.08 | $65.00 | $59.82 | $64.90 | 1 346 159 |
| 2023-01-11 | $62.88 | $62.88 | $61.02 | $62.16 | 1 695 115 |
| 2023-01-10 | $63.24 | $64.96 | $62.98 | $63.50 | 703 900 |
| 2023-01-09 | $68.11 | $68.75 | $61.26 | $63.32 | 2 233 983 |
| 2023-01-06 | $68.74 | $70.50 | $67.81 | $67.99 | 654 800 |
| 2023-01-05 | $72.00 | $72.85 | $68.66 | $69.04 | 1 162 519 |
| 2023-01-04 | $73.52 | $74.46 | $72.31 | $73.34 | 724 084 |
| 2023-01-03 | $77.70 | $77.70 | $72.88 | $73.32 | 1 089 989 |
| 2022-12-30 | $75.51 | $77.42 | $75.01 | $77.13 | 664 216 |
| 2022-12-29 | $75.88 | $78.90 | $75.13 | $76.50 | 834 295 |
| 2022-12-28 | $74.71 | $76.44 | $73.30 | $75.00 | 565 040 |
| 2022-12-27 | $74.18 | $76.96 | $73.50 | $75.53 | 645 205 |
| 2022-12-23 | $75.53 | $76.09 | $71.45 | $73.79 | 1 007 920 |
| 2022-12-22 | $74.33 | $75.49 | $73.50 | $75.13 | 625 663 |
| 2022-12-21 | $74.80 | $75.92 | $73.38 | $74.34 | 752 059 |
| 2022-12-20 | $75.18 | $76.83 | $73.41 | $74.65 | 693 481 |
| 2022-12-19 | $78.62 | $79.10 | $74.79 | $75.81 | 978 523 |
| 2022-12-16 | $76.35 | $79.67 | $75.61 | $78.40 | 1 175 937 |
| 2022-12-15 | $79.42 | $80.47 | $76.54 | $77.46 | 795 935 |
| 2022-12-14 | $79.45 | $81.16 | $77.04 | $79.72 | 802 982 |
| 2022-12-13 | $80.00 | $82.00 | $78.42 | $79.45 | 850 743 |
| 2022-12-12 | $75.00 | $79.52 | $73.65 | $79.37 | 1 019 515 |
| 2022-12-09 | $77.91 | $78.79 | $74.61 | $74.86 | 808 080 |
| 2022-12-08 | $77.83 | $79.97 | $75.80 | $77.85 | 899 679 |
| 2022-12-07 | $75.50 | $79.10 | $74.02 | $78.16 | 1 180 413 |
| 2022-12-06 | $76.37 | $78.18 | $73.58 | $75.26 | 1 080 208 |
| 2022-12-05 | $76.60 | $80.87 | $75.18 | $77.29 | 2 372 194 |
| 2022-12-02 | $71.48 | $78.00 | $70.52 | $76.90 | 2 040 801 |
| 2022-12-01 | $72.13 | $73.76 | $70.43 | $71.97 | 1 034 898 |
| 2022-11-30 | $71.17 | $74.08 | $69.26 | $72.29 | 1 643 390 |
| 2022-11-29 | $75.50 | $75.98 | $70.40 | $70.84 | 2 951 600 |
| 2022-11-28 | $71.04 | $79.68 | $68.12 | $74.74 | 10 741 789 |
| 2022-11-25 | $56.02 | $57.17 | $55.31 | $56.82 | 327 439 |
| 2022-11-23 | $57.76 | $58.04 | $55.97 | $56.22 | 771 423 |
| 2022-11-22 | $57.05 | $59.98 | $56.88 | $57.23 | 1 096 273 |
| 2022-11-21 | $56.00 | $57.95 | $55.26 | $56.98 | 914 297 |
| 2022-11-18 | $52.24 | $55.97 | $49.60 | $55.85 | 856 597 |
| 2022-11-17 | $50.29 | $54.30 | $49.81 | $52.57 | 828 034 |
| 2022-11-16 | $54.80 | $55.25 | $51.63 | $51.99 | 684 870 |
| 2022-11-15 | $55.70 | $59.26 | $54.10 | $56.01 | 1 146 882 |
About Axsome Therapeutics
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
